Cargando…
Omicron subvariant BA.5 efficiently infects lung cells
The SARS-CoV-2 Omicron subvariants BA.1 and BA.2 exhibit reduced lung cell infection relative to previously circulating SARS-CoV-2 variants, which may account for their reduced pathogenicity. However, it is unclear whether lung cell infection by BA.5, which displaced these variants, remains attenuat...
Autores principales: | , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10262933/ https://www.ncbi.nlm.nih.gov/pubmed/37311762 http://dx.doi.org/10.1038/s41467-023-39147-4 |
_version_ | 1785058134283255808 |
---|---|
author | Hoffmann, Markus Wong, Lok-Yin Roy Arora, Prerna Zhang, Lu Rocha, Cheila Odle, Abby Nehlmeier, Inga Kempf, Amy Richter, Anja Halwe, Nico Joel Schön, Jacob Ulrich, Lorenz Hoffmann, Donata Beer, Martin Drosten, Christian Perlman, Stanley Pöhlmann, Stefan |
author_facet | Hoffmann, Markus Wong, Lok-Yin Roy Arora, Prerna Zhang, Lu Rocha, Cheila Odle, Abby Nehlmeier, Inga Kempf, Amy Richter, Anja Halwe, Nico Joel Schön, Jacob Ulrich, Lorenz Hoffmann, Donata Beer, Martin Drosten, Christian Perlman, Stanley Pöhlmann, Stefan |
author_sort | Hoffmann, Markus |
collection | PubMed |
description | The SARS-CoV-2 Omicron subvariants BA.1 and BA.2 exhibit reduced lung cell infection relative to previously circulating SARS-CoV-2 variants, which may account for their reduced pathogenicity. However, it is unclear whether lung cell infection by BA.5, which displaced these variants, remains attenuated. Here, we show that the spike (S) protein of BA.5 exhibits increased cleavage at the S1/S2 site and drives cell-cell fusion and lung cell entry with higher efficiency than its counterparts from BA.1 and BA.2. Increased lung cell entry depends on mutation H69Δ/V70Δ and is associated with efficient replication of BA.5 in cultured lung cells. Further, BA.5 replicates in the lungs of female Balb/c mice and the nasal cavity of female ferrets with much higher efficiency than BA.1. These results suggest that BA.5 has acquired the ability to efficiently infect lung cells, a prerequisite for causing severe disease, suggesting that evolution of Omicron subvariants can result in partial loss of attenuation. |
format | Online Article Text |
id | pubmed-10262933 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Nature Publishing Group UK |
record_format | MEDLINE/PubMed |
spelling | pubmed-102629332023-06-14 Omicron subvariant BA.5 efficiently infects lung cells Hoffmann, Markus Wong, Lok-Yin Roy Arora, Prerna Zhang, Lu Rocha, Cheila Odle, Abby Nehlmeier, Inga Kempf, Amy Richter, Anja Halwe, Nico Joel Schön, Jacob Ulrich, Lorenz Hoffmann, Donata Beer, Martin Drosten, Christian Perlman, Stanley Pöhlmann, Stefan Nat Commun Article The SARS-CoV-2 Omicron subvariants BA.1 and BA.2 exhibit reduced lung cell infection relative to previously circulating SARS-CoV-2 variants, which may account for their reduced pathogenicity. However, it is unclear whether lung cell infection by BA.5, which displaced these variants, remains attenuated. Here, we show that the spike (S) protein of BA.5 exhibits increased cleavage at the S1/S2 site and drives cell-cell fusion and lung cell entry with higher efficiency than its counterparts from BA.1 and BA.2. Increased lung cell entry depends on mutation H69Δ/V70Δ and is associated with efficient replication of BA.5 in cultured lung cells. Further, BA.5 replicates in the lungs of female Balb/c mice and the nasal cavity of female ferrets with much higher efficiency than BA.1. These results suggest that BA.5 has acquired the ability to efficiently infect lung cells, a prerequisite for causing severe disease, suggesting that evolution of Omicron subvariants can result in partial loss of attenuation. Nature Publishing Group UK 2023-06-13 /pmc/articles/PMC10262933/ /pubmed/37311762 http://dx.doi.org/10.1038/s41467-023-39147-4 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
spellingShingle | Article Hoffmann, Markus Wong, Lok-Yin Roy Arora, Prerna Zhang, Lu Rocha, Cheila Odle, Abby Nehlmeier, Inga Kempf, Amy Richter, Anja Halwe, Nico Joel Schön, Jacob Ulrich, Lorenz Hoffmann, Donata Beer, Martin Drosten, Christian Perlman, Stanley Pöhlmann, Stefan Omicron subvariant BA.5 efficiently infects lung cells |
title | Omicron subvariant BA.5 efficiently infects lung cells |
title_full | Omicron subvariant BA.5 efficiently infects lung cells |
title_fullStr | Omicron subvariant BA.5 efficiently infects lung cells |
title_full_unstemmed | Omicron subvariant BA.5 efficiently infects lung cells |
title_short | Omicron subvariant BA.5 efficiently infects lung cells |
title_sort | omicron subvariant ba.5 efficiently infects lung cells |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10262933/ https://www.ncbi.nlm.nih.gov/pubmed/37311762 http://dx.doi.org/10.1038/s41467-023-39147-4 |
work_keys_str_mv | AT hoffmannmarkus omicronsubvariantba5efficientlyinfectslungcells AT wonglokyinroy omicronsubvariantba5efficientlyinfectslungcells AT aroraprerna omicronsubvariantba5efficientlyinfectslungcells AT zhanglu omicronsubvariantba5efficientlyinfectslungcells AT rochacheila omicronsubvariantba5efficientlyinfectslungcells AT odleabby omicronsubvariantba5efficientlyinfectslungcells AT nehlmeieringa omicronsubvariantba5efficientlyinfectslungcells AT kempfamy omicronsubvariantba5efficientlyinfectslungcells AT richteranja omicronsubvariantba5efficientlyinfectslungcells AT halwenicojoel omicronsubvariantba5efficientlyinfectslungcells AT schonjacob omicronsubvariantba5efficientlyinfectslungcells AT ulrichlorenz omicronsubvariantba5efficientlyinfectslungcells AT hoffmanndonata omicronsubvariantba5efficientlyinfectslungcells AT beermartin omicronsubvariantba5efficientlyinfectslungcells AT drostenchristian omicronsubvariantba5efficientlyinfectslungcells AT perlmanstanley omicronsubvariantba5efficientlyinfectslungcells AT pohlmannstefan omicronsubvariantba5efficientlyinfectslungcells |